ARCHIVES

Inhibitor Reduces Spleen Size By 35 Percent or More in Phase III

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

The Cloning Story: How Dolly Made Page 1 And A Physicist Got Air Time

May 15, 1998

NCCS Networker Volume 11 Issue 1, Spring 1997 Special Report: The Cancer Bill

April 13, 1997

In Brief: Three NCI Basic Science Centers Rank In Index Of Citations; Novello: Help More Smokers Quit

August 2, 1991

ODAC Recommends Approval of Gemcitabine For Pancreatic Cancer

August 4, 1995

Obituary: Lawrence Garfinkel, ACS Epidemiologist

January 22, 2010

Dear FDA: Provenge Provokes Letters From Opponents, Advocates, Investors.

April 27, 2007